Immediate Impact

7 from Science/Nature 206 hit
Sub-graph 1 of 17

Citing Papers

Psilocybin’s lasting action requires pyramidal cell types and 5-HT2A receptors
2025 HitNature
Medical, surgical, and physical treatments for Parkinson's disease
2024 Hit
58 intermediate papers

Works of Michael Kometer being referenced

Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers
2011
The 5-HT2A/1A Agonist Psilocybin Disrupts Modal Object Completion Associated with Visual Hallucinations
2010
and 10 more

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Michael Kometer 2.4k 1.5k 1.2k 588 490 37 3.0k
Robin Carhart‐Harris 3.1k 1.3× 1.5k 1.0× 1.6k 1.3× 616 1.0× 542 1.1× 65 3.8k
Christopher Timmermann 2.0k 0.8× 937 0.6× 1.1k 0.9× 317 0.5× 354 0.7× 60 2.4k
Mark Bolstridge 3.1k 1.3× 1.8k 1.2× 1.8k 1.5× 308 0.5× 538 1.1× 17 3.5k
Yasmin Schmid 2.0k 0.9× 1.2k 0.8× 832 0.7× 219 0.4× 398 0.8× 57 2.6k
Patrick C. Dolder 2.0k 0.8× 1.2k 0.8× 1.1k 0.9× 186 0.3× 415 0.8× 43 2.4k
Torsten Passie 2.1k 0.9× 1.1k 0.7× 1.1k 0.9× 190 0.3× 342 0.7× 50 2.7k
Manel J. Barbanoj 1.8k 0.8× 1.3k 0.8× 541 0.5× 780 1.3× 732 1.5× 58 3.5k
Erich Studerus 1.5k 0.6× 787 0.5× 605 0.5× 655 1.1× 241 0.5× 77 3.1k
Katherine A. MacLean 2.5k 1.1× 722 0.5× 856 0.7× 765 1.3× 267 0.5× 30 3.4k
Rick J. Strassman 2.8k 1.2× 1.5k 1.0× 1.2k 1.0× 231 0.4× 695 1.4× 52 3.8k

All Works

Loading papers...

Rankless by CCL
2026